{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:36:06Z","timestamp":1786725366665,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04931-3","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:23:37Z","timestamp":1781072617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Galectin 3 expression in gastrointestinal tumors identified through comprehensive bioinformatic mapping"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4180-5046","authenticated-orcid":false,"given":"Maurizio","family":"Chiriva-Internati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0925-742X","authenticated-orcid":false,"given":"Fabio","family":"Grizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7810-5011","authenticated-orcid":false,"given":"Mohamed A. A. A.","family":"Hegazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-281X","authenticated-orcid":false,"given":"Robert S.","family":"Bresalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"1","key":"4931_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020;159(1):335-49 e15. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.068.","journal-title":"Gastroenterology"},{"issue":"3","key":"4931_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"4931_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20043640","author":"SR Jardim","year":"2023","unstructured":"Jardim SR, de Souza LMP, de Souza HSP. The rise of gastrointestinal cancers as a global phenomenon: unhealthy behavior or progress? Int J Environ Res Public Health. 2023. https:\/\/doi.org\/10.3390\/ijerph20043640.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"4931_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S2468-1253(23)00399-0","volume":"9","author":"O Oduyale","year":"2024","unstructured":"Oduyale O, Cao Y. Charting the path forward to combat gastrointestinal cancers. Lancet Gastroenterol Hepatol. 2024;9(3):189\u201391. https:\/\/doi.org\/10.1016\/S2468-1253(23)00399-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4931_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1167337","volume":"10","author":"L Zhang","year":"2023","unstructured":"Zhang L, Wang G, Zhu L, Wei W, Zhang J. Editorial: gynecological and gastrointestinal cancers: recent advances in molecular diagnosis and targeted therapy. Front Mol Biosci. 2023;10:1167337. https:\/\/doi.org\/10.3389\/fmolb.2023.1167337.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"4931_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cdt3.36","volume":"9","author":"M Ju","year":"2023","unstructured":"Ju M, Gao Z, Li K, Wang Z. Partial advances in the diagnosis and treatment of gastrointestinal cancer. Chron Dis Transl Med. 2023;9(1):1\u20134. https:\/\/doi.org\/10.1002\/cdt3.36.","journal-title":"Chron Dis Transl Med"},{"issue":"28","key":"4931_CR7","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.3748\/wjg.v27.i28.4493","volume":"27","author":"N Bordry","year":"2021","unstructured":"Bordry N, Astaras C, Ongaro M, Goossens N, Frossard JL, Koessler T. Recent advances in gastrointestinal cancers. World J Gastroenterol. 2021;27(28):4493\u2013503. https:\/\/doi.org\/10.3748\/wjg.v27.i28.4493.","journal-title":"World J Gastroenterol"},{"key":"4931_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/415498","volume":"2012","author":"JL Chen","year":"2012","unstructured":"Chen JL, Gurski RR, Takahashi K, Andersson R. Gastrointestinal cancer metastasis. Gastroenterol Res Pract. 2012;2012: 415498. https:\/\/doi.org\/10.1155\/2012\/415498.","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"4931_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3892\/mco.2020.1985","volume":"12","author":"I Fujita","year":"2020","unstructured":"Fujita I, Toyokawa T, Makino T, Matsueda K, Omote S, Horii J. Small early gastric cancer with synchronous bone metastasis: a case report. Mol Clin Oncol. 2020;12(3):202\u20137. https:\/\/doi.org\/10.3892\/mco.2020.1985.","journal-title":"Mol Clin Oncol"},{"key":"4931_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010052","author":"A Aureli","year":"2022","unstructured":"Aureli A, Del Corno M, Marziani B, Gessani S, Conti L. Highlights on the role of galectin-3 in colorectal cancer and the preventive\/therapeutic potential of food-derived inhibitors. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers15010052.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4931_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1053\/j.gastro.2024.03.007","volume":"167","author":"D Yang","year":"2024","unstructured":"Yang D, Sun X, Moniruzzaman R, Wang H, Citu C, Zhao Z, et al. Genetic deletion of galectin-3 inhibits pancreatic cancer progression and enhances the efficacy of immunotherapy. Gastroenterology. 2024;167(2):298\u2013314. https:\/\/doi.org\/10.1053\/j.gastro.2024.03.007.","journal-title":"Gastroenterology"},{"issue":"12","key":"4931_CR12","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1002\/1097-0142(19950615)75:12<2818::AID-CNCR2820751206>3.0.CO;2-#","volume":"75","author":"HL Schoeppner","year":"1995","unstructured":"SchoeppnerHL, Raz A, Ho SB, Bresalier RS. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer. 1995;75(12):2818\u201326. https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/1097-0142%2819950615%2975%3A12%3C2818%3A%3AAID-CNCR2820751206%3E3.0.CO%3B2-%23","journal-title":"Cancer"},{"issue":"8","key":"4931_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042699","volume":"7","author":"S Song","year":"2012","unstructured":"Song S, Ji B, Ramachandran V, Wang H, Hafley M, Logsdon C, et al. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. PLoS One. 2012;7(8):e42699. https:\/\/doi.org\/10.1371\/journal.pone.0042699.","journal-title":"PLoS One"},{"issue":"2","key":"4931_CR14","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1684\/bdc.2010.1032","volume":"97","author":"A Arfaoui-Toumi","year":"2010","unstructured":"Arfaoui-Toumi A, Kria-Ben Mahmoud L, Ben Hmida M, Khalfallah MT, Regaya-Mzabi S, Bouraoui S. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients). Bull Cancer. 2010;97(2):E1-8. https:\/\/doi.org\/10.1684\/bdc.2010.1032. Epub 2010\/01\/19.","journal-title":"Bull Cancer"},{"key":"4931_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101500","author":"M Dimitrijevic Stojanovic","year":"2023","unstructured":"Dimitrijevic Stojanovic M, Stojanovic B, Radosavljevic I, Kovacevic V, Jovanovic I, Stojanovic BS, et al. Galectin-3\u2019s complex interactions in pancreatic ductal adenocarcinoma: from cellular signaling to therapeutic potential. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13101500.","journal-title":"Biomolecules"},{"issue":"5","key":"4931_CR16","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1053\/j.gastro.2017.12.014","volume":"154","author":"W Zhao","year":"2018","unstructured":"Zhao W, Ajani JA, Sushovan G, Ochi N, Hwang R, Hafley M, et al. Galectin-3 mediates tumor cell-stroma interactions by activating pancreatic stellate cells to produce cytokines via integrin signaling. Gastroenterology. 2018;154(5):1524\u201337. https:\/\/doi.org\/10.1053\/j.gastro.2017.12.014.","journal-title":"Gastroenterology"},{"issue":"2","key":"4931_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/s0016-5085(98)70195-7","volume":"115","author":"RS Bresalier","year":"1998","unstructured":"Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, et al. Metastasis of human colon cancer is altered by modifying expression of the \u03b2-galactoside-binding protein galectin 3. Gastroenterology. 1998;115(2):287\u201396. https:\/\/doi.org\/10.1016\/s0016-5085(98)70195-7.","journal-title":"Gastroenterology"},{"issue":"5","key":"4931_CR18","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1053\/j.gastro.2005.09.002","volume":"129","author":"S Song","year":"2005","unstructured":"Song S, Byrd JC, Mazurek N, Liu K, Koo JS, Bresalier RS. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation. Gastroenterology. 2005;129(5):1581\u201391. https:\/\/doi.org\/10.1053\/j.gastro.2005.09.002.","journal-title":"Gastroenterology"},{"issue":"3","key":"4931_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/cdd.2011.123","volume":"19","author":"N Mazurek","year":"2012","unstructured":"Mazurek N, Byrd JC, Sun Y, Hafley M, Ramirez K, Burks J, et al. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death Differ. 2012;19(3):523\u201333. https:\/\/doi.org\/10.1038\/cdd.2011.123.","journal-title":"Cell Death Differ"},{"issue":"8","key":"4931_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.239","volume":"7","author":"M Ilmer","year":"2016","unstructured":"Ilmer M, Mazurek N, Byrd JC, Ramirez K, Hafley M, Alt E, et al. Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics. Cell Death Dis. 2016;7(8):e2337. https:\/\/doi.org\/10.1038\/cddis.2016.239.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4931_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/bjc.2017.388","volume":"118","author":"JA Ajani","year":"2018","unstructured":"Ajani JA, Estrella JS, Chen Q, Correa AM, Ma L, Scott AW, et al. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1\/BET inhibitors. Br J Cancer. 2018;118(1):52\u201361. https:\/\/doi.org\/10.1038\/bjc.2017.388.","journal-title":"Br J Cancer"},{"issue":"8","key":"4931_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.tips.2023.06.001","volume":"44","author":"S Bouffette","year":"2023","unstructured":"Bouffette S, Botez I, De Ceuninck F. Targeting galectin-3 in inflammatory and fibrotic diseases. Trends Pharmacol Sci. 2023;44(8):519\u201331. https:\/\/doi.org\/10.1016\/j.tips.2023.06.001.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"4931_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-023-00322-4","volume":"9","author":"E Yakubovich","year":"2023","unstructured":"Yakubovich E, Cook DP, Rodriguez GM, Vanderhyden BC. Mesenchymal ovarian cancer cells promote CD8(+) T cell exhaustion through the LGALS3-LAG3 axis. NPJ Syst Biol Appl. 2023;9(1):61. https:\/\/doi.org\/10.1038\/s41540-023-00322-4.","journal-title":"NPJ Syst Biol Appl"},{"key":"4931_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121480","volume":"318","author":"JR Sharma","year":"2023","unstructured":"Sharma JR, Agraval H, Yadav UCS. Cigarette smoke induces epithelial-to-mesenchymal transition, stemness, and metastasis in lung adenocarcinoma cells via upregulated RUNX-2\/galectin-3 pathway. Life Sci. 2023;318:121480. https:\/\/doi.org\/10.1016\/j.lfs.2023.121480.","journal-title":"Life Sci"},{"issue":"4","key":"4931_CR25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1158\/0008-5472.CAN-08-4153","volume":"69","author":"S Song","year":"2009","unstructured":"Song S, Mazurek N, Liu C, Sun Y, Ding QQ, Liu K, et al. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity. Cancer Res. 2009;69(4):1343\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-4153.","journal-title":"Cancer Res"},{"issue":"1","key":"4931_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03309-1","volume":"24","author":"Y Ren","year":"2024","unstructured":"Ren Y, Qian Y, Zhang Q, Li X, Li M, Li W, et al. High LGALS3 expression induced by HCP5\/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. Cancer Cell Int. 2024;24(1):142. https:\/\/doi.org\/10.1186\/s12935-024-03309-1.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"4931_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.drup.2007.04.001","volume":"10","author":"T Fukumori","year":"2007","unstructured":"Fukumori T, Kanayama HO, Raz A. The role of galectin-3 in cancer drug resistance. Drug Resist Updat. 2007;10(3):101\u20138. https:\/\/doi.org\/10.1016\/j.drup.2007.04.001.","journal-title":"Drug Resist Updat"},{"issue":"23","key":"4931_CR28","doi-asserted-by":"publisher","first-page":"19592","DOI":"10.18632\/oncotarget.4285","volume":"6","author":"Y Harazono","year":"2015","unstructured":"Harazono Y, Kho DH, Balan V, Nakajima K, Hogan V, Raz A. Extracellular galectin-3 programs multidrug resistance through Na+\/K+-ATPase and P-glycoprotein signaling. Oncotarget. 2015;6(23):19592\u2013604. https:\/\/doi.org\/10.18632\/oncotarget.4285.","journal-title":"Oncotarget"},{"issue":"8","key":"4931_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. Ualcan: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649\u201358. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002.","journal-title":"Neoplasia"},{"issue":"5","key":"4931_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cbio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095.","journal-title":"Cancer Discov"},{"issue":"269","key":"4931_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cbioPortal. Sci Signal. 2013;6(269):pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Sci Signal"},{"issue":"23","key":"4931_CR32","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer Res. 2023;83(23):3861\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0816.","journal-title":"Cancer Res"},{"issue":"3","key":"4931_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100625","volume":"5","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Camb). 2024;5(3):100625. https:\/\/doi.org\/10.1016\/j.xinn.2024.100625.","journal-title":"Innovation (Camb)"},{"issue":"3","key":"4931_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/bph.16257","volume":"181","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024;181(3):362\u201374. https:\/\/doi.org\/10.1111\/bph.16257.","journal-title":"Br J Pharmacol"},{"issue":"W1","key":"4931_CR35","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60\u20134. https:\/\/doi.org\/10.1093\/nar\/gky311.","journal-title":"Nucleic Acids Res"},{"key":"4931_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf388","author":"H Cui","year":"2025","unstructured":"Cui H, Zhao G, Lu Y, Zuo S, Duan D, Luo X, et al. TIMER3: an enhanced resource for tumor immune analysis. Nucleic Acids Res. 2025. https:\/\/doi.org\/10.1093\/nar\/gkaf388.","journal-title":"Nucleic Acids Res"},{"key":"4931_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwaf081","author":"Y-H Hung","year":"2026","unstructured":"Hung Y-H, Li F-Y, Yang H-Y, Lai C-H, Liu F-T. Galectin-3 facilitates helicobacter pylori-induced apoptosis independently of sensing lysosomal damage. Glycobiology. 2026. https:\/\/doi.org\/10.1093\/glycob\/cwaf081.","journal-title":"Glycobiology"},{"key":"4931_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051628","author":"S Mantziari","year":"2023","unstructured":"Mantziari S, St Amour P, Abboretti F, Teixeira-Farinha H, Gaspar Figueiredo S, Gronnier C, et al. A comprehensive review of prognostic factors in patients with gastric adenocarcinoma. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15051628.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"4931_CR39","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/jgh.16930","volume":"40","author":"X Chai","year":"2025","unstructured":"Chai X, Zhang Y, Shi Z, Yang R, Liu X, Zhou Y, et al. An overview of predictive biomarkers and detection approaches for immunotherapy response in GI malignancies. J Gastroenterol Hepatol. 2025;40(5):1059\u201369. https:\/\/doi.org\/10.1111\/jgh.16930.","journal-title":"J Gastroenterol Hepatol"},{"key":"4931_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00757-3","author":"JJ Lee","year":"2025","unstructured":"Lee JJ, Ng KY, Bakhtiar A. Extracellular matrix: unlocking new avenues in cancer treatment. Biomarker Res. 2025. https:\/\/doi.org\/10.1186\/s40364-025-00757-3.","journal-title":"Biomarker Res"},{"key":"4931_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3840","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, van Tienderen GS, Schenke-Layland K, van der Laan LJW, Khalil AA, Verstegen MMA. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets. Sci Transl Med. 2024. https:\/\/doi.org\/10.1126\/scitranslmed.adg3840.","journal-title":"Sci Transl Med"},{"issue":"8","key":"4931_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","volume":"23","author":"F-T Liu","year":"2023","unstructured":"Liu F-T, Stowell SR. The role of galectins in immunity and infection. Nat Rev Immunol. 2023;23(8):479\u201394. https:\/\/doi.org\/10.1038\/s41577-022-00829-7.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"4931_CR43","doi-asserted-by":"publisher","first-page":"R406","DOI":"10.1016\/j.cub.2022.03.065","volume":"32","author":"S Banfer","year":"2022","unstructured":"Banfer S, Jacob R. Galectins. Curr Biol. 2022;32(9):R406\u20138. https:\/\/doi.org\/10.1016\/j.cub.2022.03.065.","journal-title":"Curr Biol"},{"issue":"24","key":"4931_CR44","first-page":"6239","volume":"59","author":"HC Gong","year":"1999","unstructured":"Gong HC, Honjo Y, Nangia-Makker P, Hogan V, Mazurak N, Bresalier RS, et al. The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res. 1999;59(24):6239\u201345 Epub 2000\/01\/08. PubMed PMID: 10626818.","journal-title":"Cancer Res"},{"issue":"46","key":"4931_CR45","doi-asserted-by":"publisher","first-page":"36311","DOI":"10.1074\/jbc.M003831200","volume":"275","author":"N Mazurek","year":"2000","unstructured":"Mazurek N, Conklin J, Byrd JC, Raz A, Bresalier RS. Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem. 2000;275(46):36311\u20135. https:\/\/doi.org\/10.1074\/jbc.M003831200.","journal-title":"J Biol Chem"},{"key":"4931_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1052959","volume":"10","author":"L Kruk","year":"2023","unstructured":"Kruk L, Braun A, Cosset E, Gudermann T, Mammadova-Bach E. Galectin functions in cancer-associated inflammation and thrombosis. Front Cardiovasc Med. 2023;10:1052959. https:\/\/doi.org\/10.3389\/fcvm.2023.1052959.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"4931_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-023-00636-2","volume":"22","author":"KV Mari\u00f1o","year":"2023","unstructured":"Mari\u00f1o KV, Cagnoni AJ, Croci DO, Rabinovich GA. Targeting galectin-driven regulatory circuits in cancer and fibrosis. Nat Rev Drug Discov. 2023;22(4):295\u2013316. https:\/\/doi.org\/10.1038\/s41573-023-00636-2.","journal-title":"Nat Rev Drug Discov"},{"issue":"19","key":"4931_CR48","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1002\/cncr.26078","volume":"117","author":"N Mazurek","year":"2011","unstructured":"Mazurek N, Byrd JC, Sun Y, Ueno S, Bresalier RS. A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells. Cancer. 2011;117(19):4375\u201380. https:\/\/doi.org\/10.1002\/cncr.26078.","journal-title":"Cancer"},{"issue":"29","key":"4931_CR49","doi-asserted-by":"publisher","first-page":"21337","DOI":"10.1074\/jbc.M608810200","volume":"282","author":"N Mazurek","year":"2007","unstructured":"Mazurek N, Sun YJ, Liu KF, Gilcrease MZ, Schober W, Nangia-Makker P, et al. Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells. J Biol Chem. 2007;282(29):21337\u201348. https:\/\/doi.org\/10.1074\/jbc.M608810200.","journal-title":"J Biol Chem"},{"key":"4931_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2019.101010","volume":"76","author":"RC Gilson","year":"2019","unstructured":"Gilson RC, Gunasinghe SD, Johannes L, Gaus K. Galectin-3 modulation of T-cell activation: mechanisms of membrane remodelling. Prog Lipid Res. 2019;76: 101010. https:\/\/doi.org\/10.1016\/j.plipres.2019.101010.","journal-title":"Prog Lipid Res"},{"key":"4931_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105881","volume":"130","author":"RJ Slack","year":"2021","unstructured":"Slack RJ, Mills R, Mackinnon AC. The therapeutic potential of galectin-3 inhibition in fibrotic disease. Int J Biochem Cell Biol. 2021;130:105881. https:\/\/doi.org\/10.1016\/j.biocel.2020.105881.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"4931_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01859-x","volume":"10","author":"G Wang","year":"2024","unstructured":"Wang G, Li R, Feng C, Li K, Liu S, Fu Q. Galectin-3 is involved in inflammation and fibrosis in arteriogenic erectile dysfunction via the TLR4\/MyD88\/NF-\u03baB pathway. Cell Death Discov. 2024;10(1):92. https:\/\/doi.org\/10.1038\/s41420-024-01859-x.","journal-title":"Cell Death Discov"},{"key":"4931_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03331-7","author":"X Zheng","year":"2025","unstructured":"Zheng X, Yang L, Wang W, Sun J, Li Y. LGALS3 promotes liver fibrosis by enhancing the expression and phosphorylation of ERK1\/2. Eur J Med Res. 2025. https:\/\/doi.org\/10.1186\/s40001-025-03331-7.","journal-title":"Eur J Med Res"},{"key":"4931_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cells14191521","author":"V Brza\u010dki","year":"2025","unstructured":"Brza\u010dki V, Jovanovi\u0107 A, Ran\u010di\u0107 A, Te\u0161i\u0107-Rajkovi\u0107 S, Petrovi\u0107 G, Nagorni I, et al. Circulating and tissue galectin-3 in gastrointestinal inflammation: clinical significance and biomarker potential. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14191521.","journal-title":"Cells"},{"key":"4931_CR55","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1023\/B:GLYC.0000014083.48508.6a","volume":"19","author":"F van den Br\u00fble","year":"2002","unstructured":"van den Br\u00fble F, Califice S, Castronovo V. Expression of galectins in cancer: a critical review. Glycoconj J. 2002;19:537\u201342. https:\/\/doi.org\/10.1023\/B:GLYC.0000014083.48508.6a.","journal-title":"Glycoconj J"},{"issue":"1","key":"4931_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00759-1","volume":"13","author":"N Zhang","year":"2025","unstructured":"Zhang N, Liu Q, Wang D, Wang X, Pan Z, Han B, et al. Multifaceted roles of galectins: from carbohydrate binding to targeted cancer therapy. Biomark Res. 2025;13(1):49. https:\/\/doi.org\/10.1186\/s40364-025-00759-1.","journal-title":"Biomark Res"},{"issue":"3","key":"4931_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0320441","volume":"20","author":"CY So","year":"2025","unstructured":"So CY, Li Y, Chow KT. New insights on galectin-9 expression in cancer prognosis: an updated systemic review and meta-analysis. PLoS One. 2025;20(3):e0320441. https:\/\/doi.org\/10.1371\/journal.pone.0320441.","journal-title":"PLoS One"},{"key":"4931_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science. 2015. https:\/\/doi.org\/10.1126\/science.1260419.","journal-title":"Science"},{"issue":"19","key":"4931_CR59","first-page":"4354","volume":"56","author":"RS Bresalier","year":"1996","unstructured":"Bresalier RS, Byrd JC, Wang L, Raz A. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res. 1996;56(19):4354\u20137 Epub 1996\/10\/01. PubMed PMID: 8813123.","journal-title":"Cancer Res"},{"issue":"9","key":"4931_CR60","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2305-5839.2014.09.12","volume":"2","author":"AH Ebrahim","year":"2014","unstructured":"Ebrahim AH, Alalawi Z, Mirandola L, Rakhshanda R, Dahlbeck S, Nguyen D, et al. Galectins in cancer: carcinogenesis, diagnosis and therapy. Ann Transl Med. 2014;2(9):88. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2014.09.12.","journal-title":"Ann Transl Med"},{"issue":"6","key":"4931_CR61","doi-asserted-by":"publisher","first-page":"e1434467","DOI":"10.1080\/2162402X.2018.1434467","volume":"7","author":"M Farhad","year":"2018","unstructured":"Farhad M, Rolig AS, Redmond WL. The role of galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment. Oncoimmunology. 2018;7(6):e1434467.","journal-title":"Oncoimmunology"},{"key":"4931_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-3-s2-p306","author":"S Linch","year":"2015","unstructured":"Linch S, Kasiewicz MJ, McNamara M, Hilgart I, Farhad M, Redmond W. Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. J Immunother Cancer. https:\/\/doi.org\/10.1186\/2051-1426-3-s2-p306.","journal-title":"J Immunother Cancer"},{"key":"4931_CR63","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12009","author":"M Li","year":"2021","unstructured":"Li M, Chen YB, Liu F, Qu JQ, Ren LC, Chai J, et al. Galectin\u20113 facilitates the proliferation and migration of nasopharyngeal carcinoma cells via activation of the ERK1\/2 and Akt signaling pathways, and is positively correlated with the inflammatory state of nasopharyngeal carcinoma. Mol Med Rep. 2021. https:\/\/doi.org\/10.3892\/mmr.2021.12009.","journal-title":"Mol Med Rep"},{"key":"4931_CR64","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12682","author":"A Mielczarek-Palacz","year":"2022","unstructured":"Mielczarek-Palacz A, Kondera-Anasz Z, Smycz-Kubanska M, Englisz A, Janusz A, Krolewska-Daszczynska P, et al. The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer (Review). Mol Med Rep. 2022. https:\/\/doi.org\/10.3892\/mmr.2022.12682.","journal-title":"Mol Med Rep"},{"issue":"22","key":"4931_CR65","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1158\/0008-5472.CAN-12-2424","volume":"72","author":"RR Braeuer","year":"2012","unstructured":"Braeuer RR, Zigler M, Kamiya T, Dobroff AS, Huang L, Choi W, et al. Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin. Cancer Res. 2012;72(22):5757\u201366. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2424.","journal-title":"Cancer Res"},{"issue":"4","key":"4931_CR66","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.livres.2020.11.001","volume":"4","author":"T Setayesh","year":"2020","unstructured":"Setayesh T, Colquhoun SD, Wan YY. Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma. Liver Res. 2020;4(4):173\u20139. https:\/\/doi.org\/10.1016\/j.livres.2020.11.001.","journal-title":"Liver Res"},{"issue":"1","key":"4931_CR67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10555-020-09932-4","volume":"40","author":"K Nakajima","year":"2021","unstructured":"Nakajima K, Balan V, Raz A. Galectin-3: an immune checkpoint target for musculoskeletal tumor patients. Cancer Metastasis Rev. 2021;40(1):297\u2013302. https:\/\/doi.org\/10.1007\/s10555-020-09932-4.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"4931_CR68","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<776::AID-CNCR17>3.0.CO;2-Q","volume":"80","author":"RS Bresalier","year":"1997","unstructured":"Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer. 1997;80(4):776\u201387. Epub 1997\/08\/15. PubMed PMID: 9264362.","journal-title":"Cancer"},{"issue":"7","key":"4931_CR69","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1369\/jhc.2009.952960","volume":"57","author":"FA Miranda","year":"2009","unstructured":"Miranda FA, Hassumi MK, Guimaraes MC, Simoes RT, Silva TG, Lira RC, et al. Galectin-3 overexpression in invasive laryngeal carcinoma, assessed by computer-assisted analysis. J Histochem Cytochem. 2009;57(7):665\u201373. https:\/\/doi.org\/10.1369\/jhc.2009.952960.","journal-title":"J Histochem Cytochem"},{"issue":"1\u20132","key":"4931_CR70","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2152\/jmi.57.152","volume":"57","author":"M Sakaki","year":"2010","unstructured":"Sakaki M, Fukumori T, Fukawa T, Elsamman E, Shiirevnyamba A, Nakatsuji H, et al. Clinical significance of Galectin-3 in clear cell renal cell carcinoma. J Med Invest. 2010;57(1\u20132):152\u20137. https:\/\/doi.org\/10.2152\/jmi.57.152.","journal-title":"J Med Invest"},{"issue":"9","key":"4931_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103482","volume":"9","author":"H Zhang","year":"2014","unstructured":"Zhang H, Luo M, Liang X, Wang D, Gu X, Duan C, et al. Galectin-3 as a marker and potential therapeutic target in breast cancer. PLoS One. 2014;9(9):e103482. https:\/\/doi.org\/10.1371\/journal.pone.0103482.","journal-title":"PLoS One"},{"issue":"1","key":"4931_CR72","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/ol.2017.6252","volume":"14","author":"T Shimura","year":"2017","unstructured":"Shimura T, Kofunato Y, Okada R, Yashima R, Koyama Y, Araki K, et al. Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma. Oncol Lett. 2017;14(1):819\u201329. https:\/\/doi.org\/10.3892\/ol.2017.6252.","journal-title":"Oncol Lett"},{"issue":"4","key":"4931_CR73","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ejca.2008.01.014","volume":"44","author":"M Junking","year":"2008","unstructured":"Junking M, Wongkham C, Sripa B, Sawanyawisuth K, Araki N, Wongkham S. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma. Eur J Cancer. 2008;44(4):619\u201326. https:\/\/doi.org\/10.1016\/j.ejca.2008.01.014.","journal-title":"Eur J Cancer"},{"issue":"2","key":"4931_CR74","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3892\/mmr.2014.2873","volume":"11","author":"N Liang","year":"2015","unstructured":"Liang N, Song X, Xie J, Xu D, Liu F, Yu X, et al. Effect of galectin-3 on the behavior of Eca\u2011109 human esophageal cancer cells. Mol Med Rep. 2015;11(2):896\u2013902. https:\/\/doi.org\/10.3892\/mmr.2014.2873.","journal-title":"Mol Med Rep"},{"issue":"4","key":"4931_CR75","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.3892\/ol.2018.7959","volume":"15","author":"J Zhang","year":"2018","unstructured":"Zhang J, Deng G, Qiao L, Luo H, Liu Q, Liang N, et al. Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells. Oncol Lett. 2018;15(4):4907\u201311. https:\/\/doi.org\/10.3892\/ol.2018.7959.","journal-title":"Oncol Lett"},{"issue":"4","key":"4931_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0570-6","volume":"32","author":"G Cui","year":"2015","unstructured":"Cui G, Cui M, Li Y, Liang Y, Li W, Guo H, et al. Galectin-3 knockdown increases gefitinib sensitivity to the inhibition of EGFR endocytosis in gefitinib-insensitive esophageal squamous cancer cells. Med Oncol. 2015;32(4):124. https:\/\/doi.org\/10.1007\/s12032-015-0570-6.","journal-title":"Med Oncol"},{"issue":"35","key":"4931_CR77","doi-asserted-by":"publisher","first-page":"9248","DOI":"10.1021\/acs.jafc.8b04020","volume":"66","author":"WW Xu","year":"2018","unstructured":"Xu WW, Zheng CC, Huang YN, Chen WY, Yang QS, Ren JY, et al. Synephrine hydrochloride suppresses esophageal cancer tumor growth and metastatic potential through inhibition of Galectin-3-AKT\/ERK signaling. J Agric Food Chem. 2018;66(35):9248\u201358. https:\/\/doi.org\/10.1021\/acs.jafc.8b04020.","journal-title":"J Agric Food Chem"},{"issue":"24","key":"4931_CR78","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1093\/jnci\/94.24.1854","volume":"94","author":"P Nangia-Makker","year":"2002","unstructured":"Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, et al. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst. 2002;94(24):1854\u201362. https:\/\/doi.org\/10.1093\/jnci\/94.24.1854.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"4931_CR79","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1111\/liv.15326","volume":"42","author":"E Cervantes-Alvarez","year":"2022","unstructured":"Cervantes-Alvarez E, Limon-de la Rosa N, Vilatoba M, Perez-Monter C, Hurtado-Gomez S, Martinez-Cabrera C, et al. Galectin-3 is overexpressed in advanced cirrhosis and predicts post-liver transplant infectious complications. Liver Int. 2022;42(10):2260\u201373. https:\/\/doi.org\/10.1111\/liv.15326.","journal-title":"Liver Int"},{"key":"4931_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/genes16101170","author":"G Scuderi","year":"2025","unstructured":"Scuderi G, Mijatovic S, Maksimovic-Ivanic D, Di Rosa M, Mu\u00f1oz-Valle JF, Vizca\u00edno-Quirarte AM, et al. Transcriptomic and clinical profiling reveals LGALS3 as a prognostic oncogene in pancreatic cancer. Genes. 2025. https:\/\/doi.org\/10.3390\/genes16101170.","journal-title":"Genes"},{"key":"4931_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01356-6","author":"P Sindrewicz-Goral","year":"2025","unstructured":"Sindrewicz-Goral P, Li X, Wang W, Adegbite O, Pang Y, Gledhill T, et al. Targeting galectin-3 in cancer by novel and unique inhibitors of non-carbohydrate origin. Mol Med. 2025. https:\/\/doi.org\/10.1186\/s10020-025-01356-6.","journal-title":"Mol Med"},{"key":"4931_CR82","doi-asserted-by":"publisher","DOI":"10.14440\/bladder.2024.0071","author":"AAAM Hegazi","year":"2025","unstructured":"Hegazi AAAM, Pasqualini F, Chiriva-Internati M, Taverna G, Grizzi F. SPEF1 and SPEF2 as potential biomarkers in bladder cancer: insights from a comprehensive bioinformatic analysis. Bladder. 2025. https:\/\/doi.org\/10.14440\/bladder.2024.0071.","journal-title":"Bladder"},{"issue":"22","key":"4931_CR83","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1158\/0008-5472.Can-23-0783","volume":"83","author":"Y Fan","year":"2023","unstructured":"Fan Y, Song S, Li Y, Dhar SS, Jin J, Yoshimura K, et al. Galectin-3 cooperates with CD47 to suppress phagocytosis and T-cell immunity in gastric cancer peritoneal metastases. Cancer Res. 2023;83(22):3726\u201338. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0783.","journal-title":"Cancer Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04931-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04931-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04931-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:03:04Z","timestamp":1786723384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04931-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4931"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04931-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1182"}}